Can A New Drug Screen Crack The Code On Myelin Repair?
This article was originally published in Start Up
Executive Summary
A new high-throughput assay developed at the University of California, San Francisco has already identified a generic over-the-counter drug that promotes remyelination. A clinical trial is soon to follow, only the second for myelin repair in multiple sclerosis.